Healthcare Professional Resources
Access a wide range of useful information, from
professional societies and resources to
patient education and support.
NOTE: These Web sites are external to
AstraZeneca. AstraZeneca does not possess editorial control of their content, and
no endorsement, expressed or implied, is intended.
Professional societies and resources
The American Academy of Pediatrics (AAP) is a professional
organization committed to the attainment of optimal physical, mental, and social
health and well-being for all infants, children, adolescents, and young adults.
The American College of Allergy, Asthma & Immunology (ACAAI)
is a professional association of allergists and immunologists dedicated to improving
allergy and immunology patient care through research, advocacy, and professional
public education.
The American Academy of Allergy, Asthma & Immunology (AAAAI)
is the largest professional medical specialty organization in the United States,
whose mission is the advancement of the knowledge and practice of the allergy, asthma,
and immunology specialty for optimal patient care.
The National Heart, Lung, and Blood Institute (NHLBI)
provides leadership for a national program that plans, conducts, fosters, and supports
an integrated and coordinated program of basic research, clinical investigations
and trials, observational studies, and demonstration and education projects in diseases
of the heart, blood vessels, lungs, and blood and in sleep disorders.
The National Jewish Medical and Research Center is a nonsectarian,
not-for-profit, independent, clinical, and research medical center focusing on respiratory,
immunologic, allergic, and infectious diseases.
The American Lung Association (ALA) is dedicated to the
prevention of lung disease and the promotion of lung health. The ALA supports public
education and basic and clinical research programs. Its sponsored research program,
Asthma Clinical Research Centers (ACRC), includes
20 clinical centers and a data-coordinating center to develop large clinical trials
to direct the care of people who have asthma.
The American Thoracic Society (ATS) is dedicated to the
prevention, control, and treatment of various disease states in the fields of respiratory
disease, critical care, sleep medicine, infectious disease, pediatrics, allergy/immunology,
thoracic surgery, behavioral science, and environmental and occupational medicine.
Its members help prevent and fight respiratory diseases around the globe through
education, research, patient care, and advocacy.
Patient education and support
Allergy & Asthma Network Mothers of Asthmatics, Inc.
8201 Greensboro Drive, Suite 300
McLean, VA 22102
www.aanma.org
American Lung Association
1301 Pennsylvania Avenue, NW
Washington, DC 20004
www.lungusa.org
Asthma and Allergy Foundation of America
8201 Corporate Drive, Suite 1000
Landover, MD 20785
www.aafa.org
The Consortium on Children’s Asthma Camps
490 Concordia Avenue
St. Paul, MN 55103-2441
www.asthmacamps.org
National Jewish Health
1400 Jackson Street
Denver, CO 80206
www.njc.org
IMPORTANT SAFETY INFORMATION ABOUT PULMICORT
RESPULES
PULMICORT RESPULES is not a bronchodilator and is NOT indicated for the relief of
acute bronchospasm.
Particular care is needed for patients who are transferred from systemically active
corticosteroids to PULMICORT RESPULES, because deaths due to adrenal insufficiency
have occurred in asthmatic patients during and after transfer from systemic corticosteroids
to less systemically available inhaled corticosteroids.
It is possible that systemic corticosteroid effects such as hypercorticism, reduced
bone mineral density, and adrenal suppression may appear in a small number of patients,
particularly at higher doses.
Patients taking immunosuppressant doses of corticosteroids should avoid exposure
to infections such as chicken pox and measles.
Inhaled corticosteroids may cause a reduction in growth velocity. The long-term
effect on final adult height is unknown.
Hypersensitivity reactions, including anaphylaxis, have been reported with budesonide.
As with other inhaled medications, paradoxical bronchospasm may occur with
PULMICORT
RESPULES.
In rare cases, patients on inhaled corticosteroids may present with systemic eosinophilic
conditions and clinical features consistent with Churg-Strauss Syndrome.
Adverse reactions that occurred at a rate of ≥ 3% are: respiratory infection, rhinitis, coughing, otitis media, viral infection, moniliasis, gastroenteritis, vomiting, diarrhea, abdominal pain, ear infection, epistaxis, conjunctivitis, and rash.
Indication
PULMICORT RESPULES (budesonide inhalation suspension) is indicated for the maintenance
treatment of asthma and as prophylactic therapy in children ages 12 months to 8 years.
Please
click
here
for full Prescribing Information for PULMICORT RESPULES. 